Vitrolife Breakfast Symposium
‘A personal perspective on PGT: past, present and future’?
Professor Handyside is an internationally-recognised pioneer and expert in human embryology and preimplantation genetics with an extensive research portfolio, track record for innovation in single cell diagnostics (including two patents) and 20 years’ experience in management in the private IVF sector in the UK. Professor Handyside did his first degree and PhD studies at the University of Cambridge. He developed the first transgenic mouse knockout of the HPRT gene using embryonic stem cells as a model of the human X-linked inherited disease, Lesch-Nyhan Syndrome. Afterwards he joined Prof. Lord Robert Winston at Hammersmith Hospital, London and in 1990 achieved the first pregnancies worldwide following IVF and preimplantation genetic testing (PGT) of inherited disease.
Previously Professor Handyside has been director and consultant in preimplantation genetics at the Bridge Clinic, London for twenty years and Principal Scientist at Illumina. He has recently joined Vitrolife as a Scientific Advisor.
|Venue:||Hotel Grand Chancellor Hobart
Grand Ballroom 1&2
|Date:||Tuesday 17 September 2019|
|Time:||7am – 8.15am|
|Speaker:||Dr Alan Handyside|
Registration for the breakfast can be made through the Conference delegate registration form.
If you have NOT ALREADY REGISTERED to attend the breakfast through the Conference delegate registration form, you can register at the link below: